Patient Resources
Get Healthy!
GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers
- May 30, 2025
- HealthDayTV HealthDay Reporter
A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.
Diabetes: Type IIDiabetes: Misc.ObesityCancer: BreastCancer: ColonCancer: RectalCancer: PancreaticCancer: Bladder
